Skip to content

Multicenter Validation of the PREDICT Score

Multicenter Validation of the PREDICT Score for Prediction of Local Recurrence After Total Mesorectal Excision of Rectal Cancer

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05078515
Enrollment
262
Registered
2021-10-14
Start date
2008-01-01
Completion date
2021-08-01
Last updated
2021-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rectal Cancer

Brief summary

Even after adequate TME with grade III mesorectal grading, local recurrence remains a possible event. Several studies investigated different parameters and assessed their predictive power in regards to local recurrence after TME. These parameters included a variety of patient-related, tumor-related, and treatment-related factors. A recent meta-analysis reviewed the current literature for the predictors of local recurrence after TME for rectal cancer and developed a prognostic scoring system, the PREDICT score. The present study aimed to validate the PREDICT scoring system by applying it to a prospective cohort of patients with rectal cancer who underwent curative TME in three

Interventions

DIAGNOSTIC_TESTPREDICT score

Predictive score for local recurrence after TME for rectal cancer that includes 8 parameters

Sponsors

Mansoura University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult patients of either sex with non-metastatic low or middle rectal cancer who underwent elective TME with curative intent

Exclusion criteria

* Patients with recurrent or metastatic rectal cancer at the time of presentation * Patients with synchronous colon cancer * Patients with missing data on the outcome of TME.

Design outcomes

Primary

MeasureTime frameDescription
Sensitivity of PREDICT score36 months after surgeryThe ability of the score to predict actual cases of recurrence after TME
Specificity of PREDICT score36 months after surgeryThe ability of the score to predict patients who did not experience recurrence after TME

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026